Comment
doi: 10.1053/j.ajkd.2015.04.001.
Epub 2015 May 8.
Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?
Affiliations
- PMID: 25960301
- DOI: 10.1053/j.ajkd.2015.04.001
Item in Clipboard
Comment
Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?
Am J Kidney Dis.
2015 Aug.
No abstract available
Comment in
-
Restricting Metformin in CKD: Continued Caution Warranted.Am J Kidney Dis. 2015 Dec;66(6):1101-2. doi: 10.1053/j.ajkd.2015.07.039. Am J Kidney Dis. 2015. PMID: 26593314 Free PMC article. No abstract available.
-
In Reply to 'Restricting Metformin in CKD: Continued Caution Warranted'.Am J Kidney Dis. 2015 Dec;66(6):1102. doi: 10.1053/j.ajkd.2015.09.012. Am J Kidney Dis. 2015. PMID: 26593315 No abstract available.
Comment on
-
Metformin in patients with type 2 diabetes and kidney disease: a systematic review.JAMA. 2014 Dec 24-31;312(24):2668-75. doi: 10.1001/jama.2014.15298. JAMA. 2014. PMID: 25536258 Free PMC article.
Similar articles
-
Restricting Metformin in CKD: Continued Caution Warranted.Am J Kidney Dis. 2015 Dec;66(6):1101-2. doi: 10.1053/j.ajkd.2015.07.039. Am J Kidney Dis. 2015. PMID: 26593314 Free PMC article. No abstract available.
-
In Reply to 'Restricting Metformin in CKD: Continued Caution Warranted'.Am J Kidney Dis. 2015 Dec;66(6):1102. doi: 10.1053/j.ajkd.2015.09.012. Am J Kidney Dis. 2015. PMID: 26593315 No abstract available.
-
Metformin OK in CKD?Drug Ther Bull. 2014 Apr;52(4):37. doi: 10.1136/dtb.2014.4.0244. Epub 2014 Apr 3. Drug Ther Bull. 2014. PMID: 24698854 No abstract available.
-
Metformin: time to review its role and safety in chronic kidney disease.Med J Aust. 2019 Jul;211(1):37-42. doi: 10.5694/mja2.50239. Epub 2019 Jun 12. Med J Aust. 2019. PMID: 31187887 Review.
-
[Proposal for the modification of metformin use in patients with chronic kidney disease].Orv Hetil. 2012 Sep 30;153(39):1527-35. doi: 10.1556/OH.2012.29448. Orv Hetil. 2012. PMID: 23000419 Review. Hungarian.
Cited by
-
Metformin associated lactic acidosis (MALA): clinical profiling and management.J Nephrol. 2016 Dec;29(6):783-789. doi: 10.1007/s40620-016-0267-8. Epub 2016 Jan 22. J Nephrol. 2016. PMID: 26800971 Review.
-
Restricting Metformin in CKD: Continued Caution Warranted.Am J Kidney Dis. 2015 Dec;66(6):1101-2. doi: 10.1053/j.ajkd.2015.07.039. Am J Kidney Dis. 2015. PMID: 26593314 Free PMC article. No abstract available.
-
Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.Nephron. 2017;135(2):147-153. doi: 10.1159/000450862. Epub 2016 Oct 20. Nephron. 2017. PMID: 27760420 Free PMC article.
-
Therapy: Risk of metformin use in patients with T2DM and advanced CKD.Nat Rev Endocrinol. 2015 Dec;11(12):697-9. doi: 10.1038/nrendo.2015.132. Epub 2015 Aug 18. Nat Rev Endocrinol. 2015. PMID: 26284445
-
Further clarifying the relationship between metformin, acute kidney injury and lactic acidosis.Nat Rev Nephrol. 2017 Dec 13;14(1):70. doi: 10.1038/nrneph.2017.174. Nat Rev Nephrol. 2017. PMID: 29234161 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
